70 related articles for article (PubMed ID: 17490646)
1. The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes.
Scuoppo C; Riess I; Schmitt-Ney M; Allegra P; Forni PE; Bersani F; Taulli R; Accornero P; Crepaldi T; Ponzetto C
Exp Cell Res; 2007 Jul; 313(11):2308-17. PubMed ID: 17490646
[TBL] [Abstract][Full Text] [Related]
2. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?
Charytonowicz E; Cordon-Cardo C; Matushansky I; Ziman M
Cancer Lett; 2009 Jul; 279(2):126-36. PubMed ID: 19008039
[TBL] [Abstract][Full Text] [Related]
3. Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein.
Nabarro S; Himoudi N; Papanastasiou A; Gilmour K; Gibson S; Sebire N; Thrasher A; Blundell MP; Hubank M; Canderan G; Anderson J
J Exp Med; 2005 Nov; 202(10):1399-410. PubMed ID: 16287709
[TBL] [Abstract][Full Text] [Related]
4. Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma.
Kikuchi K; Tsuchiya K; Otabe O; Gotoh T; Tamura S; Katsumi Y; Yagyu S; Tsubai-Shimizu S; Miyachi M; Iehara T; Hosoi H
Biochem Biophys Res Commun; 2008 Jan; 365(3):568-74. PubMed ID: 18022385
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein.
Xia SJ; Rajput P; Strzelecki DM; Barr FG
Lab Invest; 2007 Apr; 87(4):318-25. PubMed ID: 17297479
[TBL] [Abstract][Full Text] [Related]
6. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis.
Graf Finckenstein F; Shahbazian V; Davicioni E; Ren YX; Anderson MJ
Oncogene; 2008 Mar; 27(14):2004-14. PubMed ID: 17922034
[TBL] [Abstract][Full Text] [Related]
7. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma.
Barr FG
Cancer Res; 1999 Apr; 59(7 Suppl):1711s-1715s. PubMed ID: 10197585
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.
Finckenstein FG; Davicioni E; Osborn KG; Cavenee WK; Arden KC; Anderson MJ
Transgenic Res; 2006 Oct; 15(5):595-614. PubMed ID: 16952014
[TBL] [Abstract][Full Text] [Related]
9. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.
Scheidler S; Fredericks WJ; Rauscher FJ; Barr FG; Vogt PK
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9805-9. PubMed ID: 8790412
[TBL] [Abstract][Full Text] [Related]
10. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target.
Mercado GE; Xia SJ; Zhang C; Ahn EH; Gustafson DM; Laé M; Ladanyi M; Barr FG
Genes Chromosomes Cancer; 2008 Jun; 47(6):510-20. PubMed ID: 18335505
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis.
Miller PJ; Hollenbach AD
Biochim Biophys Acta; 2007 Oct; 1770(10):1450-8. PubMed ID: 17698292
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S
Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674
[TBL] [Abstract][Full Text] [Related]
13. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
Kempf BE; Vogt PK
Cell Growth Differ; 1999 Dec; 10(12):813-8. PubMed ID: 10616906
[TBL] [Abstract][Full Text] [Related]
14. PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN.
Li HG; Wang Q; Li HM; Kumar S; Parker C; Slevin M; Kumar P
Cancer Lett; 2007 Aug; 253(2):215-23. PubMed ID: 17350164
[TBL] [Abstract][Full Text] [Related]
15. The cooperative transforming effects of PAX3-FKHR and IGF-II on mouse myoblasts.
Wang W; Slevin M; Kumar S; Kumar P
Int J Oncol; 2005 Oct; 27(4):1087-96. PubMed ID: 16142327
[TBL] [Abstract][Full Text] [Related]
16. AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.
Jothi M; Nishijo K; Keller C; Mal AK
Cell Cycle; 2012 Mar; 11(5):895-908. PubMed ID: 22333587
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma.
Ginsberg JP; Davis RJ; Bennicelli JL; Nauta LE; Barr FG
Cancer Res; 1998 Aug; 58(16):3542-6. PubMed ID: 9721857
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.
Xia SJ; Barr FG
Oncogene; 2004 Sep; 23(41):6864-71. PubMed ID: 15286710
[TBL] [Abstract][Full Text] [Related]
19. [Influences of PAX3-FKHR transfection on expression of MRF4 and differentiation of cultured human rhabdomyosarcoma RD cells].
Li GH; Wang DL; Wang Y; Chen ZT; Li DZ
Ai Zheng; 2003 Jan; 22(1):30-4. PubMed ID: 12561432
[TBL] [Abstract][Full Text] [Related]
20. High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts.
Xia SJ; Holder DD; Pawel BR; Zhang C; Barr FG
Am J Pathol; 2009 Dec; 175(6):2600-8. PubMed ID: 19893043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
